Literature DB >> 2066241

Oral contraceptives and breast cancer: a French case-control study.

F Clavel1, N Andrieu, B Gairard, A Brémond, L Piana, J Lansac, G Bréart, C Rumeau-Rouquette, R Flamant, R Renaud.   

Abstract

The relationship between the risk of breast cancer and oral contraceptive use was investigated in a case-control study conducted in France between 1983 and 1987 in five public hospitals. Some 464 cases aged 25 to 56 years and 542 matched controls were interviewed about their history of the use of oral contraceptives (OC). Results are given for the entire population and for the subgroup of 358 and 379 premenopausal cases and controls. The multivariate relative risk estimate, for ever user, was 1.5 (p less than 0.01) in the whole group as well as in the premenopausal subgroup (p less than 0.02). However, there was no evidence that the effect varied appreciably according to duration of use, age at first use, use before first full-term pregnancy (FFTP) and time since first or last use. The risk was not altered for any particular brand of OC. We conclude that, because of the widespread attention given to the relationship between OC use and breast cancer, information bias might be responsible for part of the excess in risk observed among OC ever users.

Entities:  

Keywords:  Bias; Biology; Breast Cancer; Cancer; Contraception; Contraceptive Methods; Control Groups; Data Analysis; Data Collection; Demographic Factors; Developed Countries; Diseases; Error Sources; Europe; Family Planning; France; Measurement; Mediterranean Countries; Neoplasms; Oral Contraceptives; Population; Population Characteristics; Research Methodology; Risk Factors; Statistical Regression; Western Europe

Mesh:

Substances:

Year:  1991        PMID: 2066241     DOI: 10.1093/ije/20.1.32

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  7 in total

1.  Progestogen-only oral contraceptives and risk of breast cancer in New Zealand.

Authors:  D C Skegg; C Paul; G F Spears; S M Williams
Journal:  Cancer Causes Control       Date:  1996-09       Impact factor: 2.506

Review 2.  Oral contraceptives and cancer. A review of the evidence.

Authors:  C La Vecchia; A Tavani; S Franceschi; F Parazzini
Journal:  Drug Saf       Date:  1996-04       Impact factor: 5.606

3.  Body fat distribution and risk of premenopausal breast cancer in the Nurses' Health Study II.

Authors:  Holly R Harris; Walter C Willett; Kathryn L Terry; Karin B Michels
Journal:  J Natl Cancer Inst       Date:  2010-12-16       Impact factor: 13.506

4.  Oral contraceptive use and breast cancer risk among African-American women.

Authors:  J R Palmer; L Rosenberg; R S Rao; B L Strom; M E Warshauer; S Harlap; A Zauber; S Shapiro
Journal:  Cancer Causes Control       Date:  1995-07       Impact factor: 2.506

Review 5.  Use of Oral Contraceptives as a Potential Risk Factor for Breast Cancer: A Systematic Review and Meta-Analysis of Case-Control Studies Up to 2010.

Authors:  Wiesław Kanadys; Agnieszka Barańska; Maria Malm; Agata Błaszczuk; Małgorzata Polz-Dacewicz; Mariola Janiszewska; Marian Jędrych
Journal:  Int J Environ Res Public Health       Date:  2021-04-27       Impact factor: 3.390

6.  The effects of interaction between familial and reproductive factors on breast cancer risk: a combined analysis of seven case-control studies.

Authors:  N Andrieu; T Smith; S Duffy; D G Zaridze; R Renaud; T Rohan; M Gerber; E Luporsi; M Lê; H P Lee; Y Lifanova; N E Day
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

7.  Familial risk, abortion and their interactive effect on the risk of breast cancer--a combined analysis of six case-control studies.

Authors:  N Andrieu; S W Duffy; T E Rohan; M G Lê; E Luporsi; M Gerber; R Renaud; D G Zaridze; Y Lifanova; N E Day
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.